In comparison to Semaglutide and Tirzepatide, retatrutide's unique inclusion of glucagon receptor agonism along with GIP and GLP-1 receptor agonism offers a definite pharmacological profile. Whilst Semaglutide is a GLP-one receptor agonist and Tirzepatide combines GLP-one and GIP receptor agonism, retatrutide's triple mechanism could perhaps provide broader metabolic Gains. NiceRx https://corepepptides.com/product/retatrutide-injection-pen/